FDG-PET for predicting the prognosis of malignant lymphoma
FDG-PET for predicting the prognosis of malignant lymphoma
复制标题
FDG-PET预测恶性淋巴瘤预后
DOI：
10.1007/bf03164996
复制
发表时间：
1994
影响因子：
2.6
通讯作者：
N. Arimizu
中科院分区：
文献类型：
--
作者：
J. Okada;H. Oonishi;K. Yoshikawa;J. Itami;K. Uno;Keiko Imaseki;N. Arimizu
为了评估 FDG-PET 作为预后预测指标的有效性，对 34 名未经治疗的头颈部恶性淋巴瘤患者进行了研究。 FDG-PET 和治疗后，观察 15 至 50 个月。具有侵袭性且对治疗有抵抗力的肿瘤往往表现出对 FDG 的高摄取。 FDG高摄取、DAR>8的患者的生存率低于其他患者。将肿瘤的FDG摄取添加到其他预后因素中被认为对于预测预后是有用的。
To evaluate the usefulness of FDG-PET as a predictor of prognosis, 34 patients with untreated malignant lymphoma in the head and neck region were studied. After FDG-PET and treatment, they were observed from 15 to 50 months. Tumors which were aggressive and resistant to treatment tended to show high uptake of FDG. The survival rate of patients with high uptake of FDG, DAR > 8, was lower than the rate of the other patients. It is considered to be useful to add FDG uptake of the tumor to other prognostic factors for predicting the prognosis.
使用 2-氟-18-氟-2-脱氧-D-葡萄糖进行正电子发射断层扫描在恶性黑色素瘤成像中的初步评估。
DOI：
--
发表时间：
1993
期刊：
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
影响因子：
--
作者：
Gritters,LS;Francis,IR;Zasadny,KR;Wahl,RL
通讯作者：
Wahl,RL